Cancer Detection Startup Secures $4M to Expand Access in Underserved Communities
beHuman's $4 million seed round was led by Santé Ventures, with participation from DHVP.io. It will help expand its footprint.
Visana Health Secures $10.1M for Virtual Women’s Health Platform
Visana Health's seed funding was led by Flare Capital Partners and Frist Cressey Ventures and included participation from InHealth Ventures, Oxeon Partners, Pixel Perfect Ventures and Venture Investors. In total, the company has raised more than $13 million.
presented by
Enhanced Direct Enrollment: Georgia Access and the Power of Partnership
Across the nation, state-based health insurance exchanges are searching for ways to better serve their communities while making enrollment easier, more personal, and more accessible for everyone.
Allermi Raises $3.5M in Seed Funding To Grow DTC Allergy Relief Platform
Allermi's $3.5 million seed funding was led by Nelstone Ventures and included participation from FourSight Capital Partners. The company will use the money to expand nationally.
Tuned Secures $3.5M To Grow Hearing Care Platform for Employers
The funding round was led by Distributed Ventures and included participation from Idealab NY and Elements Health Ventures. Tuned plans to use the funding to contract with more employers and third party administrators, said Danny Aronson, co-founder and CEO of the startup.
With $14M in Seed Funding, Midi Health Aims To Provide Midlife Hormonal Care Nationally
The seed funding was co-led by Felicis Ventures and SemperVirens. Midi Health will use the $14 million to expand beyond California, form new partnerships and train and hire additional staff.
Antidote Health nabs $12M in seed round to grow AI-driven virtual HMO
The company offers clinical triage via an artificial intelligence-powered chatbot and unlimited virtual visits through a majority of its plans. Inspired by the Israeli healthcare system, patients on Antidote plans pay a monthly membership fee.
presented by
Esperion Sets Its Sights on New Areas While Maintaining Commitment to Cardiovascular Health
In a recent interview, Esperion president and CEO, Sheldon Koenig talks about the reality of statin intolerance and his company’s expansion into new diseases